Cetera Investment Advisers
IMNM icon

Cetera Investment Advisers’s Immunome IMNM Stock Holding History

Cetera Investment Advisers’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$262K Sell
11,983
-2,022
-14% -$45K ﹤0.01% 4093
2025
Q4 		$301K Sell
14,005
-11,356
-45% -$199K ﹤0.01% 3904
2025
Q3 		$297K Buy
+25,361
New +$252K ﹤0.01% 3840
2024
Q4 		– Sell
-13,529
Closed -$198K – 3835
2024
Q3 		$198K Sell
13,529
-54,473
-80% -$774K ﹤0.01% 3385
2024
Q2 		$823K Sell
68,002
-55,096
-45% -$862K ﹤0.01% 2221
2024
Q1 		$3.04M Buy
+123,098
New +$2.5M 0.01% 1273

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Cetera Investment Advisers's IMNM Position: Q1 2026 in Review

Cetera Investment Advisers reduced its Immunome (IMNM) stake by 14% in Q1 2026, selling an estimated $45K and leaving 11,983 shares worth $262K. The position accounts for ﹤0.01% of the portfolio, ranked #4093.

Cetera Investment Advisers first reported a position in IMNM in Q1 2024 and has held it in 6 quarters since. The position peaked at $3.04M in Q1 2024. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Cetera Investment Advisers held 11,983 shares of Immunome worth $262K as of Q1 2026.
  • Cetera Investment Advisers sold 2,022 Immunome shares in Q1 2026, an estimated $45K.
  • Immunome made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #4093 holding.
  • Cetera Investment Advisers first reported a position in Immunome in Q1 2024 and has held it in 6 quarters since.
  • Cetera Investment Advisers's Immunome position peaked at $3.04M in Q1 2024.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.